330 related articles for article (PubMed ID: 37489540)
21. Antihypertensive drug associated angioedema: effect modification by race/ethnicity.
Reichman ME; Wernecke M; Graham DJ; Liao J; Yap J; Chillarige Y; Southworth MR; Keeton S; Goulding MR; Mott K; Kelman JA
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1190-1196. PubMed ID: 28722207
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
Chrysant SG; Stimpel M
J Cardiovasc Pharmacol; 1998 Mar; 31(3):384-90. PubMed ID: 9514183
[TBL] [Abstract][Full Text] [Related]
24. Associations of thiazide use with skin cancers: a systematic review and meta-analysis.
Shao SC; Lai CC; Chen YH; Lai EC; Hung MJ; Chi CC
BMC Med; 2022 Jul; 20(1):228. PubMed ID: 35794547
[TBL] [Abstract][Full Text] [Related]
25. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
[TBL] [Abstract][Full Text] [Related]
26. Telmisartan/hydrochlorothiazide-induced nevus-associated cutaneous melanoma: first report in the medical literature.
Tchernev G; Patterson JW
Expert Rev Clin Pharmacol; 2021 Mar; 14(3):289-293. PubMed ID: 33576302
[No Abstract] [Full Text] [Related]
27. Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: A case/non-case study.
Lecaros-Astorga DA; Molina-Guarneros JA; Rodríguez-Jiménez P; Martin-Arias LH; Sainz-Gil M
Int J Clin Pharmacol Ther; 2021 Apr; 59(4):280-288. PubMed ID: 33355085
[TBL] [Abstract][Full Text] [Related]
28. Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients.
Letellier T; Leborgne F; Kerleau C; Gaultier A; Dantal J; Ville S;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1804-1813. PubMed ID: 33172936
[TBL] [Abstract][Full Text] [Related]
29. Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data.
Kim JC; Kim YC; Choi JW
Clin Exp Dermatol; 2021 Jun; 46(4):680-686. PubMed ID: 33215728
[TBL] [Abstract][Full Text] [Related]
30. Use of hydrochlorothiazide in Denmark following publication of skin cancer risk findings.
Pottegård A; Bech BH; Pedersen SA; Christensen B
Pharmacoepidemiol Drug Saf; 2021 Nov; 30(11):1611-1616. PubMed ID: 34435407
[TBL] [Abstract][Full Text] [Related]
31. Is there a Link between Non Melanoma Skin Cancer and Hydrochlorothiazide?
Gallelli L; Cione E; Siniscalchi A; Vasta G; Guerra A; Scaramuzzino A; Longo L; Muraca L; De Sarro G; G Sp Working Group ; Leuzzi G; Gerace A; Scuteri A; Vasapollo P; Natale V; Zampogna S; Luciani F
Curr Drug Saf; 2022; 17(3):211-216. PubMed ID: 34732119
[TBL] [Abstract][Full Text] [Related]
32. Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study.
Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
J Am Acad Dermatol; 2021 Mar; 84(3):669-675. PubMed ID: 32791082
[TBL] [Abstract][Full Text] [Related]
33. Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone.
Waeber B; Aschwanden R; Sadecky L; Ferber P
J Hypertens; 2001 Nov; 19(11):2097-104. PubMed ID: 11677377
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme inhibitors and cough. Prevalence in an outpatient medical clinic population.
Sebastian JL; McKinney WP; Kaufman J; Young MJ
Chest; 1991 Jan; 99(1):36-9. PubMed ID: 1984982
[TBL] [Abstract][Full Text] [Related]
35. [Hydrochlorothiazide use and risk of skin cancers: A systematic review].
Becquart O; Guillot B; Bourrain JL; Duflos C; Du-Thanh A
Rev Med Interne; 2019 Sep; 40(9):617-622. PubMed ID: 31101331
[TBL] [Abstract][Full Text] [Related]
36. [Hydrochlorothiazide and skin cancer].
Olde Engberink RHG; van der Hoeven NV; Zwinderman AH; van den Born BH
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120217
[TBL] [Abstract][Full Text] [Related]
37. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
Yokoyama K; Yang W; Preblick R; Frech-Tamas F
J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
[TBL] [Abstract][Full Text] [Related]
38. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitor-Based Treatment on Cardiovascular Outcomes in Hypertensive Blacks Versus Whites.
Ogedegbe G; Shah NR; Phillips C; Goldfeld K; Roy J; Guo Y; Gyamfi J; Torgersen C; Capponi L; Bangalore S
J Am Coll Cardiol; 2015 Sep; 66(11):1224-1233. PubMed ID: 26361152
[TBL] [Abstract][Full Text] [Related]
39. Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide.
Benz J; Oshrain C; Henry D; Avery C; Chiang YT; Gatlin M
J Clin Pharmacol; 1997 Feb; 37(2):101-7. PubMed ID: 9055135
[TBL] [Abstract][Full Text] [Related]
40. Importance of accounting for timing of time-varying exposures in association studies: Hydrochlorothiazide and non-melanoma skin cancer.
Danieli C; Moura CS; Pilote L; Bernatsky S; Abrahamowicz M
Pharmacoepidemiol Drug Saf; 2023 Dec; 32(12):1411-1420. PubMed ID: 37528702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]